Rare variants identified in the HNF-4α β-cell-specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and young onset Type II diabetes

18Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims/hypothesis. The recently identified alternative promoter (P2) of HNF-4α is the major HNF-4α transcription start site in pancreatic beta cells. The significance of the P2 promoter was shown by the identification of a mutation in the IPF-1 binding site of the alternative promoter which cosegregated with diabetes in a large MODY family. The role of the P2 promoter and the associated alternative exon 1 in both MODY and polygenic Type II (non-insulin-dependent) diabetes mellitus is not known. Linkage to this region in studies of Type II diabetes makes the P2 region a strong candidate for a role in Type II diabetes susceptibility. Methods. To assess the role of the P2 region we screened MODY, young-onset Type II diabetic subjects, and probands from Type II diabetes families linked to chromosome 20 for variants of the P2 promoter and associated exon of HNF-4α. Results. Two variants were found that were not present in the control subjects. The -79C/T substitution was present in a MODY family but did not perfectly cosegregate with diabetes. A -276G/T substitution was identified in two UK young-onset diabetes pro-bands but did not co-segregate with diabetes. Reporter gene studies did not indicate changes in transcriptional activity caused by either the -79C/T or -276G/T single nucleotide substitutions. Conclusion/interpretation. We found no evidence to suggest that variation in the P2 proximal promoter region and associated alternative exon 1 of HNF-4α contribute to young onset Type II diabetes susceptibility in Northern Europeans.

References Powered by Scopus

Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity

271Citations
N/AReaders
Get full text

A transcription factor regulatory circuit in differentiated pancreatic cells

220Citations
N/AReaders
Get full text

Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs

208Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Genetic Variation Near the Hepatocyte Nuclear Factor-4α Gene Predicts Susceptibility to Type 2 Diabetes

249Citations
N/AReaders
Get full text

Mutations in GCK and HNF-1α explain the majority of cases with clinical diagnosis of MODY in Spain

90Citations
N/AReaders
Get full text

A genome-wide scan in families with maturity-onset diabetes of the young: Evidence for further genetic heterogeneity

61Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mitchell, S., Vaxillaire, M., Thomas, H., Parrizas, M., Benmezroua, Y., Costa, A., … Frayling, T. (2002). Rare variants identified in the HNF-4α β-cell-specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and young onset Type II diabetes. Diabetologia, 45(9), 1344–1348. https://doi.org/10.1007/s00125-002-0913-7

Readers over time

‘10‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘2202468

Readers' Seniority

Tooltip

Researcher 8

40%

PhD / Post grad / Masters / Doc 7

35%

Lecturer / Post doc 3

15%

Professor / Associate Prof. 2

10%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 9

36%

Biochemistry, Genetics and Molecular Bi... 7

28%

Medicine and Dentistry 6

24%

Nursing and Health Professions 3

12%

Save time finding and organizing research with Mendeley

Sign up for free
0